EMA launches survey for patients and healthcare professionals on knowledge of reporting adverse reactions - Federal Office for Safety in Health Care (BASG) recommends participation The European Medicines Agency (EMA) has launched a -> Survey survey…

Two related clusters involving autochthonous transmission of chikungunya virus have been detected in the cities of Anzio and Rome, two areas located 60 km apart in the Lazio region of Italy. Transmission of this type, in areas where Aedes albopictus mosquitoes are established and at a time when environmental conditions are suitable for increased mosquito abundance and activity, is not unexpected

The Federal Office for Public Health Safety has been informed by the Romanian authority that 6 additional confirmed human WNV (meningitis/meningoencephalitis) infections have occurred.

The Federal Office for Safety in Health Care was informed about the second confirmed human WNV infection (asymptomatic course, no known travel activity) in the area of Lower Austria.

The Federal Office for Public Health Safety has been informed by the Italian authority that several autochthonous chikungunya cases have been recorded in Anzio (Rome Province, Lazio Region).

The Federal Office for Public Health Safety has been informed by the Greek authority that, in addition to the Argolida region (Argos-Mycenae and Nafplio) already notified, Epidavros in the Argolida region and the Arcadia region (North Kynouria, adjacent to Argolida) are to be classified as WNV - risk areas.

The Federal Office for Public Health Safety has been informed by the Greek authorities that five confirmed locally acquired malaria cases have been recorded in Greece.

The Federal Office for Safety in Health Care was informed about several suspected cases of WNV in the area of Vienna, Lower Austria and Burgenland. Currently, a confirmed human WNV infection can be confirmed (no travel activity, only stays in Lower Austria and Burgenland).

"AOP Orphan Pharmaceuticals AG" informed its supplied customers by letter dated August 31, 2017, that "Thromboreductin 1.0 mg Capsules" was placed on the market as a medicinal product not authorized in Austria in this strength with defective…

The Federal Office for Public Health Safety was informed by the Romanian authority that 10 human WNV infections (neuro-invasive diseases) were confirmed in the regions of county llfov, county lalomita, county Giurgiu, county Buzau, county Constanta and county Bacau, as well as in the capital Bucharest.